"I will be forever grateful to the Sontag Foundation for the award that first gave my lab wings and led to its initial discoveries."
About DSA-Funded Research
Dr. Gilbertson's research is focused on understanding the link between normal development and the origins of cancer, particularly brain tumors. His lab was the first to describe a cancer stem cell niche; demonstrate that a solid cancer can arise from tissue specific stem cells; use innovative cross-species genomics to trace the developmental origins of pediatric brain tumors; and to use whole genome sequencing to identify novel subgroup-specific mutations in medulloblastoma and ependymoma. His research has been translated into numerous diagnostic tests and innovative clinical trials for children with cancer.
Director, Cambridge Cancer Centre, University of Cambridge
Li Ka-Shing Chair of Oncology, Cambridge Cancer Centre
Head, Department of Oncology, Cambridge Cancer Centre
Senior Group Leader, Cancer Research UK (CRUK) Cambridge Institute
University of Newcastle upon Tyne, B. M.S., Pediatric Brain Tumors
University of Newcastle upon Tyne, M.B.B.S., Medicine
University of Newcastle upon Tyne, Ph.D., Pediatric Neuro-Oncology
Royal Victoria Infirmary and Freeman Hospital, Newcastle, House Officer, Medicine and Surgery
Royal Victoria Infirmary and General Hospital, Newcastle, Senior House Officer, Pediatrics
Medical School Cancer Research, Clinical Training Fellow, Pediatric Neuro-Oncology